TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ZOETIS | Delayed Deutsche Boerse AG 06:29:07 2024-05-10 EDT | ||
| 1.14 EUR | 0.00% |
|
| Current month | -8.06% | ||
| 1 month | -0.87% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 1.14 | 0.00% | 0 |
| 24-05-09 | 1.14 | -2.56% | 0 |
| 24-05-08 | 1.17 | +2.63% | 0 |
| 24-05-07 | 1.14 | -2.56% | 0 |
| 24-05-06 | 1.17 | +2.63% | 0 |
Delayed Quote Deutsche Boerse AG
Last update May 10, 2024 at 06:29 am
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | 
Société Générale
|
| WKN | SF936R |
| ISIN | DE000SF936R3 |
| Date issued | 2021-12-08 |
| Strike | 291.3 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.66 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.71 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 0.87% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
168.1
USD
Average target price
211
USD
Spread / Average Target
+25.49%
- Stock Market
- Certificates
- Certificat